Cargando…

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas

Diffuse lower-grade gliomas (LGG) represent the highly heterogeneous and infiltrative neoplasms in the central nervous system (CNS). Replication factor C 2 (RFC2) is a subunit of the RFC complex that modulates DNA replication and repair. However, the prognosis value of RFC2 and its association with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xu, Wang, Yuzhu, Li, Jing, Qu, Fengyi, Fu, Xing, Liu, Siqi, Wang, Xuan, Xie, Yuchen, Zhang, Xiaozhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873322/ https://www.ncbi.nlm.nih.gov/pubmed/35210438 http://dx.doi.org/10.1038/s41598-022-06197-5

Ejemplares similares

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

A five‐microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower‐grade glioma
por: Zhang, Jian‐Hua, et al.
Publicado: (2020)

A Metabolic Plasticity-Based Signature for Molecular Classification and Prognosis of Lower-Grade Glioma
por: Yang, Ming-Chun, et al.
Publicado: (2022)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
por: Zhang, Qiang, et al.
Publicado: (2021)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma
por: Li, Jing, et al.
Publicado: (2022)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
por: Wan, Yanzhi, et al.
Publicado: (2023)

Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
por: Yu, Huihan, et al.
Publicado: (2022)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas
por: Li, Jinxing, et al.
Publicado: (2021)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

Contrasting effects of Elg1–RFC and Ctf18–RFC inactivation in the absence of fully functional RFC in fission yeast
por: Kim, Jiyoung, et al.
Publicado: (2005)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019)

Transcription Factor Signatures May Predict the Prognosis and Status of the Immune Microenvironment of Primary Lower-Grade Gliomas
por: Liu, Peidong, et al.
Publicado: (2021)

A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma
por: Feng, Qinglin, et al.
Publicado: (2021)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma
por: He, Yongze, et al.
Publicado: (2022)

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
por: Qian, Zenghui, et al.
Publicado: (2018)

Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)

Regulation of PCNA cycling on replicating DNA by RFC and RFC-like complexes
por: Kang, Mi-Sun, et al.
Publicado: (2019)

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomas
por: Yu, Hai, et al.
Publicado: (2021)

A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma
por: Lu, Zhuangzhuang, et al.
Publicado: (2022)

Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas
por: Zheng, Yi, et al.
Publicado: (2021)

Identification of purity and prognosis‐related gene signature by network analysis and survival analysis in brain lower grade glioma
por: Xiong, Zujian, et al.
Publicado: (2020)

Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma
por: Liu, Zhizheng, et al.
Publicado: (2021)

The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas
por: Dénes, Anna, et al.
Publicado: (2023)

AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide
por: Li, Jing, et al.
Publicado: (2021)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
por: Ji, Xiaoshuai, et al.
Publicado: (2020)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2018)

Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8mf30llgq1fg80pq481moi1vh6